Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney disease

Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney disease - DPP-4 inhibitors in CKD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009493

Enrollment

Registered

2012-12-07

Start date

2011-09-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

DPP-4 inhibitor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Exclusion criteria are the presence of infectious disease, thyroid disease, malignant tumors and treatment with steroids.

Design outcomes

Primary

Measure	Time frame
Glycemic control	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026